This blog provides 3 major ways for biotech and pharmaceutical companies to accelerate and streamline the development of cell and gene therapies.
Tag: Real-world Evidence
Data Manager allows clients to include large, real-world datasets in their customer presentations in an efficient, compliant manner
On July 15, the US FDA published its goals and commitment letters for the re-authorization of its Prescription Drug User Fee Act (PDUFA) for fiscal years 2018-2022, known as PDUFA VI. The document reflects the agency’s performance and procedural goals to expedite bringing safer therapies to patients. It also reflects and incorporates the advances in … Continued